Intermittent fasting
Intermittent fasting is one of the hottest topics in longevity. In animal studies the results are promising, but in controlled human trials the picture is more modest: fasting works mainly because people eat less, and no better than an ordinary diet with the same calories.
difference in weight loss between 16:8 and three regular meals in the TREAT trial, not significant [2]
In an NEJM trial, an eating window added nothing to a diet with the same calories [3]
There is no long-term study yet of whether fasting extends human life [1]
The methods
Time-restricted eating (for example 16:8, eating only within 8 hours a day), the 5:2 method (two days a week of very little food), and alternate-day fasting. The review by de Cabo and Mattson in NEJM (2019) describes the mechanism: the body switching from burning sugar to burning fat, and improvements in metabolic markers.
What the trials found
In the TREAT trial (2020), 116 people with overweight ate for 12 weeks either within a 12:00 to 20:00 window or three regular meals. The difference in weight loss between the groups was 0.26 kg and not significant.
In Liu's NEJM trial (2022), 139 people with obesity had the same calorie limit for a year, some also with an 8:00 to 16:00 eating window. Weight loss was 8.0 kg versus 6.3 kg, a difference that was not significant.
The fasting-mimicking diet
The fasting-mimicking diet (FMD) is five days in a row of eating very little, about 700 to 1,100 calories a day, low in sugar and protein and high in unsaturated fat. It's done once a month, and the rest of the month you eat normally. The idea: get some of fasting's effects on the body without fasting completely.
In Wei's trial (2017), 100 healthy people were split into two groups. Those who did three five-day cycles lost weight and fat, and their blood pressure fell, as did IGF-1, a growth hormone linked to aging. Drops in sugar, cholesterol and CRP were found mainly in people who started with high values. A further analysis of the trial data (Brandhorst, 2024) calculated a drop of about two and a half years in biological age.
What isn't known yet: the trials were small, lasted three months, and didn't look at disease or death. Biological age is a measure calculated from blood tests, not a health outcome. There's also a conflict of interest: the kit is sold by a company (L-Nutra) in which the lead researcher, Valter Longo, holds shares, and USC receives royalties from it. Longo has said his shares will go to charity.
Bottom line: an interesting method with good early results on markers, but it hasn't been shown to extend life. The same caveats as for fasting apply here, and anyone on medication should talk to a doctor first.
So who is it for?
If an eating window helps you eat less and stop snacking at night, it is a legitimate approach. If it leads to overeating within the window, there are other ways. What matters is what you can stick with.
Fasting is not for everyone. People on diabetes medication (especially insulin), pregnant or breastfeeding women, and anyone with a history of eating disorders should consult a doctor first.
Myth or fact
"Fasting extends life, it's proven"What do we know?
What we know: Proven in animals. In humans there is no long-term study of life expectancy yet.
"You can eat anything within the eating window"What do we know?
What we know: In the trials, the benefit came mainly from eating less. Overeating within the window cancels it.
Sources
- de Cabo and Mattson 2019: intermittent fasting, health and aging (NEJM)
- Lowe 2020: the TREAT trial (JAMA Intern Med)
- Liu 2022: calorie restriction with or without an eating window (NEJM)
- Wei 2017: fasting-mimicking diet and risk factors (Sci Transl Med)
- Brandhorst 2024: fasting-mimicking diet and biological age (Nat Commun)
General research-based information, not medical advice and not a substitute for a doctor. Before a significant change, especially with an illness or medication, talk to a professional.